Wiseman AC - Search Results

1

Risk of ESKD in Older Live Kidney Donors with Hypertension.

Al Ammary F, Luo X, Muzaale AD, Massie AB, Crews DC, Waldram MM, Qadi MA, Garonzik-Wang J, Henderson ML, Brennan DC, Wiseman AC, Lindrooth RC, Snyder JJ, Coresh J, Segev DL. Al Ammary F, et al. Among authors: wiseman ac. Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1048-1055. doi: 10.2215/CJN.14031118. Epub 2019 Jun 25. Clin J Am Soc Nephrol. 2019. PMID: 31239252 Free PMC article.

2

Twelve-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation.

Weiss AS, Smits G, Wiseman AC. Weiss AS, et al. Among authors: wiseman ac. Clin J Am Soc Nephrol. 2009 May;4(5):988-95. doi: 10.2215/CJN.04940908. Epub 2009 Apr 30. Clin J Am Soc Nephrol. 2009. PMID: 19406961 Free PMC article.

3

Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection.

Huskey J, Gralla J, Wiseman AC. Huskey J, et al. Among authors: wiseman ac. Clin J Am Soc Nephrol. 2011 Feb;6(2):423-9. doi: 10.2215/CJN.04210510. Epub 2010 Nov 18. Clin J Am Soc Nephrol. 2011. PMID: 21088287 Free PMC article.

4

Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes.

Wiseman AC, Gralla J. Wiseman AC, et al. Clin J Am Soc Nephrol. 2012 Apr;7(4):656-64. doi: 10.2215/CJN.08310811. Epub 2012 Feb 16. Clin J Am Soc Nephrol. 2012. PMID: 22344508

5

The risk of acute rejection and the influence of induction agents in lower-risk African American kidney transplant recipients receiving modern immunosuppression.

Gralla J, Le CN, Cooper JE, Wiseman AC. Gralla J, et al. Among authors: wiseman ac. Clin Transplant. 2014 Mar;28(3):292-8. doi: 10.1111/ctr.12311. Epub 2014 Jan 30. Clin Transplant. 2014. PMID: 24476453

6

Induction Therapy in Renal Transplantation: Why? What Agent? What Dose? We May Never Know.

Wiseman AC. Wiseman AC. Clin J Am Soc Nephrol. 2015 Jun 5;10(6):923-5. doi: 10.2215/CJN.03800415. Epub 2015 May 15. Clin J Am Soc Nephrol. 2015. PMID: 25979977 Free PMC article. No abstract available.

7

Immunosuppressive Medications.

Wiseman AC. Wiseman AC. Clin J Am Soc Nephrol. 2016 Feb 5;11(2):332-43. doi: 10.2215/CJN.08570814. Epub 2015 Jul 13. Clin J Am Soc Nephrol. 2016. PMID: 26170177 Free PMC article. Review.

8

Live donor kidney - PAK versus SPK: how to decide?

Stites E, Wiseman AC. Stites E, et al. Among authors: wiseman ac. Curr Opin Organ Transplant. 2017 Aug;22(4):377-381. doi: 10.1097/MOT.0000000000000435. Curr Opin Organ Transplant. 2017. PMID: 28538038 Review.

9

Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation.

Davis S, Gralla J, Klem P, Tong S, Wedermyer G, Freed B, Wiseman A, Cooper JE. Davis S, et al. Am J Transplant. 2018 Apr;18(4):907-915. doi: 10.1111/ajt.14504. Epub 2017 Oct 24. Am J Transplant. 2018. PMID: 28925597 Free PMC article.

10

Protecting Donors and Safeguarding Altruism in the United States: The Living Donor Protection Act.

Wiseman AC. Wiseman AC. Clin J Am Soc Nephrol. 2018 May 7;13(5):790-792. doi: 10.2215/CJN.13681217. Epub 2018 Mar 9. Clin J Am Soc Nephrol. 2018. PMID: 29523678 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page